Companies: 10,795·Total market cap: $144.5T
Trinity Biotech plc

Trinity Biotech plc

TRIBNASDAQHealthcare● Active
$0.71
+$0.03(+5.13%)
Market Cap$7425737
P/E Ratio
52W High$3.44
52W Low$0.5

Trinity Biotech plc (TRIB) Revenue

Annual & quarterly revenue history · segment & region breakdown

TRIB · revenue · updated Jun 9, 2026

Core revenue metrics

Trinity Biotech plc trailing twelve-month (TTM) revenue is $0.04B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.04B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.16×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$115K
380 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Trinity Biotech plc SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
TRIB revenue by year · TRIB revenue history · TRIB annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Trinity Biotech plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Trinity Biotech plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Trinity Biotech plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

TRIB revenue · 4 questions

TRIB's trailing twelve-month (TTM) revenue is $0.04B. That is an increase of 0.00% year-over-year from — in FY.

TRIB revenueTRIB annual revenuewhat is TRIB revenueTRIB TTM revenue

Source: FMP · Trinity Biotech plc SEC filings · GAAP · Trinity Biotech plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026